target audience: TECH BUYER Publication date: Dec 2022 - Document type: IDC MarketScape - Doc Document number: # US48061622
IDC MarketScape: Worldwide Life Science R&D Pharmacovigilance Solutions 2022 Vendor Assessment
Content
List of Tables
List of Figures
Related Links
Table of Contents
-
IDC MarketScape Figure
-
Figure: IDC MarketScape Worldwide Life Science R&D Pharmacovigilance Solutions Vendor Assessment
-
-
IDC Opinion
-
IDC MarketScape Vendor Inclusion Criteria
-
Advice for Technology Buyers
-
Vendor Summary Profiles
-
Accenture
-
Strengths
-
Challenges
-
Consider Accenture When
-
ArisGlobal
-
Strengths
-
Challenges
-
Consider ArisGlobal When
-
Cognizant
-
Strengths
-
Challenges
-
Consider Cognizant When
-
Indegene
-
Strengths
-
Challenges
-
Consider Indegene When
-
IQVIA
-
Strengths
-
Challenges
-
Consider IQVIA When
-
Navitas Life Sciences
-
Strengths
-
Challenges
-
Consider Navitas Life Sciences When
-
Oracle
-
Strengths
-
Challenges
-
Consider Oracle When
-
PwC
-
Strengths
-
Challenges
-
Consider PwC When
-
Sarjen Systems
-
Strengths
-
Challenges
-
Consider Sarjen Systems When
-
TCS
-
Strengths
-
Challenges
-
Consider TCS When
-
Veeva
-
Strengths
-
Challenges
-
Consider Veeva When
-
Vendors to Watch
-
-
Appendix
-
Reading an IDC MarketScape Graph
-
IDC MarketScape Methodology
-
Market Definition
-
Market Overview
-
Strategies and Capabilities Criteria
-
Table: Key Strategy Measures for Success: Worldwide Life Science R&D Pharmacovigilance Solutions
-
Table: Key Capability Measures for Success: Worldwide Life Science R&D Pharmacovigilance Solutions
-
-
Learn More
-
Related Research
-
Synopsis
-